脂肪酸代谢:中医药治疗肾纤维化的机遇与挑战
肾纤维化是慢性肾脏病进展至终末期肾病的关键病理过程,目前缺乏明确有效的逆转措施,脂肪酸代谢紊乱高度参与其中。本文综述中医药调控脂肪酸代谢改善肾纤维化的机制与核心靶点,指出中药复方多靶点优势带来机遇,但面临机制复杂性、标准化与临床转化等挑战。
要点
- 脂肪酸代谢紊乱通过脂毒性、线粒体损伤、免疫炎症等驱动肾纤维化。
- 中医药口服联合针灸、灌肠、纳米递送等外治方式展现调控优势。
- 未来需整合多组学、新型递送系统与病证结合模型推进转化。
核心结论
- 中医药基于复杂成分的多靶点优势在调控脂肪酸代谢改善肾纤维化方面展现机遇,但机制复杂性、标准化和临床转化仍是挑战。
研究设计与样本
- 本文为综述,围绕中医药调控脂肪酸代谢改善肾纤维化的机制与核心靶点进行梳理。
主要发现
- 脂肪酸代谢失调下的脂毒性、线粒体损伤、免疫炎症、表观遗传、代谢重编程及肠-肾轴等分子串扰驱动肾小管、肾小球和间质损伤。
- 靶向脂肪酸代谢改善肾纤维化的治疗策略已成研究热点,但多数药物仍处于临床探索阶段,许多生物标志物的预测和治疗价值尚待验证。
- 中医药以口服联合针灸、灌肠、纳米递送等外治的个性化现代化方式,在靶向脂肪酸代谢改善肾纤维化方面日益显现优势。
临床怎么用
- 可关注中医药调控脂肪酸代谢这一环节,作为改善肾纤维化的潜在干预方向。
- 临床可结合口服与针灸、灌肠等外治方式,但需注意多数药物仍处于临床探索阶段。
局限性
- 当前研究面临机制复杂性、中医药标准化和临床转化等挑战。
- 多数靶向脂肪酸代谢的药物仍处于临床探索阶段,许多生物标志物的预测和治疗价值尚待验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Renal fibrosis (RF), as a critical pathological process in the progression of chronic kidney disease (CKD) to end-stage renal disease, currently lacks clear and effective reversal measures. Disordered fatty acid metabolism is highly involved in this process. Studies have revealed that molecular crosstalk under fatty acid metabolism dysregulation-such as lipotoxicity, mitochondrial damage, immune inflammation, epigenetics, metabolic reprogramming, and the gut-kidney axis-drives damage to renal tubules, glomeruli, and the interstitium. Therapeutic strategies targeting fatty acid metabolism to ameliorate RF have gradually become a research hotspot, though most current drugs are still in the clinical exploration stage, and the predictive and therapeutic value of many biomarkers remains to be validated. Traditional Chinese Medicine (TCM), with its personalized and modernized approach combining oral administration and external treatments such as acupuncture, enema, and nanodelivery, is increasingly demonstrating advantages in targeting fatty acid metabolism to improve RF. This review outlines the mechanisms and core targets of TCM in regulating fatty acid metabolism to ameliorate RF. The multi-target advantage based on complex components presents an opportunity for TCM to improve RF, though current research still faces challenges such as mechanistic complexity, standardization of TCM, and clinical translation. Future efforts should integrate multi-omics technologies, novel drug delivery systems, and disease-syndrome combination models to advance the development of new integrated Chinese and Western medicine drugs for RF.
引用
- Gao RR, Han C, Li W, et al. Fatty acid metabolism: opportunities and challenges of traditional Chinese medicine in the treatment of renal fibrosis. Chin Med. 2026. PMID: 41566544. doi:10.1186/s13020-026-01328-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。